T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma

Lignende værker

• Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
  af: Postow, Michael A., et al.
  Udgivet: (2015)
• Patterns of long-term survival following Ipilimumab (Ipi): the Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience
  af: Page, David B, et al.
  Udgivet: (2014)
• Immunomodulatory Therapy for Melanoma: Ipilimumab and Beyond
  af: Callahan, Margaret K., et al.
  Udgivet: (2013)
• The heterogeneity of the kinetics of response to ipilimumab in metastatic melanoma: patient cases
  af: Saenger, Yvonne M., et al.
  Udgivet: (2008)
• Ipilimumab in patients with melanoma and autoimmune disease
  af: Kyi, Chrisann, et al.
  Udgivet: (2014)